Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China, 710061.
✉ Corresponding author: Zhikui Liu, Ph.D., MD, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an 710061, China. E-mail: liuzhikui.1234com; Phone: +086-029-85323905; Fax: +086-029-85323209More
Citation:
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583. https://www.ijbs.com/v18p3942.htm
Wang, L., Sun, L., Wang, Y., Yao, B., Liu, R., Chen, T., Tu, K., Liu, Q., Liu, Z. (2022). miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. International Journal of Biological Sciences, 18(10), 3942. https://doi.org/10.7150/ijbs.75583.
ACS
Wang, L.; Sun, L.; Wang, Y.; Yao, B.; Liu, R.; Chen, T.; Tu, K.; Liu, Q.; Liu, Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int. J. Biol. Sci. 2022, 18 (10), 3942. DOI: 10.7150/ijbs.75583.
NLM
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci 2022; 18(10):3942. doi:10.7150/ijbs.75583. https://www.ijbs.com/v18p3942.htm
CSE
Wang L, Sun L, Wang Y, Yao B, Liu R, Chen T, Tu K, Liu Q, Liu Z. 2022. miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction. Int J Biol Sci. 18(10):3942.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.